FI842532A - Imidazokinazolinfoerening. - Google Patents

Imidazokinazolinfoerening. Download PDF

Info

Publication number
FI842532A
FI842532A FI842532A FI842532A FI842532A FI 842532 A FI842532 A FI 842532A FI 842532 A FI842532 A FI 842532A FI 842532 A FI842532 A FI 842532A FI 842532 A FI842532 A FI 842532A
Authority
FI
Finland
Prior art keywords
imidazokinazolinfoerening
tetrahydroimidazo
quinazolin
piperidino
solubility
Prior art date
Application number
FI842532A
Other languages
English (en)
Other versions
FI842532A0 (fi
FI77864B (fi
FI77864C (fi
Inventor
Fumiyoshi Ishikawa
Shinichiro Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI842532A0 publication Critical patent/FI842532A0/fi
Publication of FI842532A publication Critical patent/FI842532A/fi
Publication of FI77864B publication Critical patent/FI77864B/fi
Application granted granted Critical
Publication of FI77864C publication Critical patent/FI77864C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Furan Compounds (AREA)
FI842532A 1983-06-21 1984-06-21 Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart 7-piperidino-1,2,3,5-tetrahydroimidazo /2,1-b/kinazolin-2-on. FI77864C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11149883 1983-06-21
JP58111498A JPS604186A (ja) 1983-06-21 1983-06-21 イミダゾキナゾリン化合物

Publications (4)

Publication Number Publication Date
FI842532A0 FI842532A0 (fi) 1984-06-21
FI842532A true FI842532A (fi) 1984-12-22
FI77864B FI77864B (fi) 1989-01-31
FI77864C FI77864C (fi) 1989-05-10

Family

ID=14562811

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842532A FI77864C (fi) 1983-06-21 1984-06-21 Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart 7-piperidino-1,2,3,5-tetrahydroimidazo /2,1-b/kinazolin-2-on.

Country Status (19)

Country Link
US (1) US4596806A (fi)
EP (1) EP0129258B1 (fi)
JP (1) JPS604186A (fi)
KR (1) KR910003153B1 (fi)
AT (1) ATE29884T1 (fi)
AU (1) AU558124B2 (fi)
CA (1) CA1231946A (fi)
DE (1) DE3466392D1 (fi)
DK (1) DK162999C (fi)
ES (1) ES533609A0 (fi)
FI (1) FI77864C (fi)
GR (1) GR81629B (fi)
IE (1) IE57736B1 (fi)
IL (1) IL72188A (fi)
NO (1) NO161220C (fi)
PH (1) PH19413A (fi)
PT (1) PT78775A (fi)
YU (1) YU43576B (fi)
ZA (1) ZA844437B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
ZA851131B (en) * 1984-02-15 1986-09-24 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)oxyalkylamides
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4766126A (en) * 1986-01-10 1988-08-23 Daiichi Seiyaku Co., Ltd. Process for treatment of nephritis with imidazoquinazolines
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4761416A (en) * 1986-07-25 1988-08-02 Syntex (U.S.A.) Inc. N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Also Published As

Publication number Publication date
EP0129258A1 (en) 1984-12-27
ES8603483A1 (es) 1985-12-16
ZA844437B (en) 1985-01-30
PT78775A (en) 1984-07-01
AU558124B2 (en) 1987-01-22
GR81629B (fi) 1984-12-11
EP0129258B1 (en) 1987-09-23
NO161220C (no) 1989-07-19
FI842532A0 (fi) 1984-06-21
NO161220B (no) 1989-04-10
JPS635030B2 (fi) 1988-02-01
KR850000442A (ko) 1985-02-27
IE57736B1 (en) 1993-03-24
IE841549L (en) 1984-12-21
FI77864B (fi) 1989-01-31
DE3466392D1 (de) 1987-10-29
IL72188A (en) 1987-03-31
YU43576B (en) 1989-08-31
CA1231946A (en) 1988-01-26
US4596806A (en) 1986-06-24
DK162999C (da) 1992-06-01
YU107884A (en) 1986-10-31
FI77864C (fi) 1989-05-10
NO842502L (no) 1984-12-27
DK290084A (da) 1984-12-22
DK162999B (da) 1992-01-06
PH19413A (en) 1986-04-10
ATE29884T1 (de) 1987-10-15
AU2943284A (en) 1985-01-03
ES533609A0 (es) 1985-12-16
KR910003153B1 (ko) 1991-05-20
JPS604186A (ja) 1985-01-10
DK290084D0 (da) 1984-06-13
IL72188A0 (en) 1984-10-31

Similar Documents

Publication Publication Date Title
DE3684631D1 (de) Direkt gesteuerte drehmaschine.
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
DE3582474D1 (de) Korpuskularstrahlgeraet.
ES296385Y (es) Perno conico.
FI842532A (fi) Imidazokinazolinfoerening.
FI854425A0 (fi) Anordning foer uppvaermning av passagerarutrymmen eller liknande, speciellt i bussar.
FI834897A (fi) Anordning foer avskiljning av bark fraon traed.
FI853321A0 (fi) Centrifug foer torkning av foertorkat slam.
DE267400T1 (de) Drehmaschine.
FI844051L (fi) Foerfarande foer dehalogenering av 6, 6-dibrompenicillansyra-1,1-dioxid.
FI844900L (fi) Foerfarande foer framstaellning av 4,5,6,7-tetrahydrotiazolo/5,4-c/pyridinderivat.
FI852961A0 (fi) Foerfarande foer framstaellning av alkylestrar av -(4-hydroxi-3,5-di-tert.butylfenyl)-propionsyra.
FI832398L (fi) Foerfarande foer kontrollering av processmaeltan av en gjutmaessing i tvao faser.
FI842338A (fi) 2-azabicyklo/2.2.2./oktanderivat, foerfarande foer framstaellning av dessa samt dessa innehaollande farmaceutiska aemnen.
FI843527L (fi) Foerfarande foer framstaellning av dihydroaryloxialkylamino -1,2,4-triazolderivat.
FI880733A (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
FI890065A0 (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.
FI840057A (fi) Foerfarande foer framstaellning av formade produkter innehaollande tvaerbunden polyolefin.
FI880150A0 (fi) Anordning foer toemning av en saedesbehaollare i en skoerdetroeska.
ES272251Y (es) Disposicion perfeccionada del bombillo de una cerradura.
FI844050A0 (fi) Foerfarande foer framstaellning av 6,6-dibrompenicillansyra-1,1-dioxid.
FI842268A0 (fi) Foerfarande foer framstaellning av 3,4-di -isobutyryloxi-n-metyl-fenetylamin.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: DAIICHI SEIYAKI CO. LTD.